We are in the midst of a powerful psychedelic renaissance. After four decades of hibernation, the promise of the psychoactive 60s - that deeper self-awareness, achieved through reality-bending substances and practices, will lead to greater external harmony - is again gaining a major following. The signs are everywhere, from the influence of today's preeminent psychedelic thinker Daniel Pinchbeck, to the renewed interest in the legacy of Terence McKenna, and to the upsurge of collective cultural phenomena like the spectacle of Burning Man.

The use of entheogens, or psychedelics, is out of the closet today. LSD, psilocybin, MDMA, and other medicines once associated only with the counterculture are now being legally studied for their healing properties. But as Rachel Harris shows, the underground use and study of psychedelics by women dates back to the Eleusinian Mysteries of ancient Greece. Harris interviews the modern women elders carrying on this tradition to gather their hard-won wisdom of experience.

In this extraordinary best seller, James Hillman presents a brilliant vision of our selves, and an exciting approach to the mystery at the center of every life that asks, “What is it, in my heart, that I must do, be, and have? And why?” Drawing on the biographies of figures such as Ella Fitzgerald and Mohandas K. Gandhi, Hillman argues that character is fate, that there is more to each individual than can be explained by genetics and environment. The result is a reasoned and powerful road map to understanding our true nature and discovering an eye-opening array of choices.

Exploring the latest developments in the flourishing field of modern psychedelic psychotherapy, this book shares practical experiences and insights from both elders and newer research voices in the psychedelic research and clinical communities.

Few drugs in history have generated as much controversy as MDMA—or held as much promise. Once vilified as a Schedule I substance that would supposedly eat holes in users’ brains, MDMA (also known as Molly or Ecstasy) is now being hailed as a therapeutic agent that could transform the field of mental health and outpace psilocybin and ketamine as the first psychedelic approved for widespread clinical use. In I Feel Love, science journalist Rachel Nuwer separates fact from fantasy, hope from hype, in the drug’s contested history and still-evolving future.